nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0288	0.0366	CbGbCtD
Cyclophosphamide—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.02	0.0253	CbGbCtD
Cyclophosphamide—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.019	0.024	CbGbCtD
Cyclophosphamide—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0188	0.0238	CbGbCtD
Cyclophosphamide—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0188	0.0238	CbGbCtD
Cyclophosphamide—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0178	0.0226	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0178	0.0226	CbGbCtD
Cyclophosphamide—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.017	0.0215	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0154	0.0195	CbGbCtD
Cyclophosphamide—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0154	0.0195	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0149	0.019	CbGbCtD
Cyclophosphamide—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0149	0.019	CbGbCtD
Cyclophosphamide—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0148	0.0188	CbGbCtD
Cyclophosphamide—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0142	0.0181	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0135	0.0171	CbGbCtD
Cyclophosphamide—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0135	0.0171	CbGbCtD
Cyclophosphamide—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0135	0.0171	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0135	0.0171	CbGbCtD
Cyclophosphamide—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0134	0.017	CbGbCtD
Cyclophosphamide—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0134	0.017	CbGbCtD
Cyclophosphamide—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0129	0.0163	CbGbCtD
Cyclophosphamide—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0129	0.0163	CbGbCtD
Cyclophosphamide—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0129	0.0163	CbGbCtD
Cyclophosphamide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0127	0.0161	CbGbCtD
Cyclophosphamide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0119	0.0151	CbGbCtD
Cyclophosphamide—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0115	0.0146	CbGbCtD
Cyclophosphamide—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0112	0.0142	CbGbCtD
Cyclophosphamide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0108	0.0137	CbGbCtD
Cyclophosphamide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0108	0.0137	CbGbCtD
Cyclophosphamide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0106	0.0134	CbGbCtD
Cyclophosphamide—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0101	0.0129	CbGbCtD
Cyclophosphamide—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0101	0.0129	CbGbCtD
Cyclophosphamide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00992	0.0126	CbGbCtD
Cyclophosphamide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00992	0.0126	CbGbCtD
Cyclophosphamide—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00975	0.0124	CbGbCtD
Cyclophosphamide—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00975	0.0124	CbGbCtD
Cyclophosphamide—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00965	0.0122	CbGbCtD
Cyclophosphamide—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00963	0.0122	CbGbCtD
Cyclophosphamide—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00935	0.0119	CbGbCtD
Cyclophosphamide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00932	0.0118	CbGbCtD
Cyclophosphamide—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00907	0.0115	CbGbCtD
Cyclophosphamide—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00907	0.0115	CbGbCtD
Cyclophosphamide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00904	0.0115	CbGbCtD
Cyclophosphamide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00897	0.0114	CbGbCtD
Cyclophosphamide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00897	0.0114	CbGbCtD
Cyclophosphamide—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00871	0.011	CbGbCtD
Cyclophosphamide—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0082	0.0104	CbGbCtD
Cyclophosphamide—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0082	0.0104	CbGbCtD
Cyclophosphamide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00818	0.0104	CbGbCtD
Cyclophosphamide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00818	0.0104	CbGbCtD
Cyclophosphamide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00784	0.00995	CbGbCtD
Cyclophosphamide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00774	0.00982	CbGbCtD
Cyclophosphamide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00752	0.00954	CbGbCtD
Cyclophosphamide—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00752	0.00953	CbGbCtD
Cyclophosphamide—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0073	0.00926	CbGbCtD
Cyclophosphamide—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00708	0.00898	CbGbCtD
Cyclophosphamide—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00687	0.00872	CbGbCtD
Cyclophosphamide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0068	0.00863	CbGbCtD
Cyclophosphamide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0068	0.00863	CbGbCtD
Cyclophosphamide—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0066	0.00837	CbGbCtD
Cyclophosphamide—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0066	0.00837	CbGbCtD
Cyclophosphamide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00652	0.00827	CbGbCtD
Cyclophosphamide—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00633	0.00803	CbGbCtD
Cyclophosphamide—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00622	0.00789	CbGbCtD
Cyclophosphamide—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00622	0.00789	CbGbCtD
Cyclophosphamide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00614	0.00778	CbGbCtD
Cyclophosphamide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00577	0.00732	CbGbCtD
Cyclophosphamide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00577	0.00732	CbGbCtD
Cyclophosphamide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00522	0.00662	CbGbCtD
Cyclophosphamide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00522	0.00662	CbGbCtD
Cyclophosphamide—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00489	0.00621	CbGbCtD
Cyclophosphamide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0045	0.00571	CbGbCtD
Cyclophosphamide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00437	0.00555	CbGbCtD
Cyclophosphamide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00395	0.00502	CbGbCtD
Cyclophosphamide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00395	0.00502	CbGbCtD
Cyclophosphamide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00379	0.00481	CbGbCtD
Cyclophosphamide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000845	0.0546	CbGeAlD
Cyclophosphamide—CYP2C18—digestive system—acquired immunodeficiency syndrome	0.000765	0.0494	CbGeAlD
Cyclophosphamide—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000738	0.0476	CbGeAlD
Cyclophosphamide—CYP2C18—vagina—acquired immunodeficiency syndrome	0.000675	0.0436	CbGeAlD
Cyclophosphamide—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000666	0.043	CbGeAlD
Cyclophosphamide—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000662	0.0427	CbGeAlD
Cyclophosphamide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000655	0.0423	CbGeAlD
Cyclophosphamide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.0005	0.0323	CbGeAlD
Cyclophosphamide—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000492	0.0318	CbGeAlD
Cyclophosphamide—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000446	0.0288	CbGeAlD
Cyclophosphamide—CYP2A6—lung—acquired immunodeficiency syndrome	0.000422	0.0273	CbGeAlD
Cyclophosphamide—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000354	0.0228	CbGeAlD
Cyclophosphamide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000325	0.021	CbGeAlD
Cyclophosphamide—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000318	0.0205	CbGeAlD
Cyclophosphamide—CYP2C19—blood—acquired immunodeficiency syndrome	0.00031	0.02	CbGeAlD
Cyclophosphamide—CYP2A6—brain—acquired immunodeficiency syndrome	0.000299	0.0193	CbGeAlD
Cyclophosphamide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000287	0.0185	CbGeAlD
Cyclophosphamide—CYP2C8—blood—acquired immunodeficiency syndrome	0.00027	0.0175	CbGeAlD
Cyclophosphamide—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000258	0.0166	CbGeAlD
Cyclophosphamide—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000256	0.0165	CbGeAlD
Cyclophosphamide—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000254	0.0164	CbGeAlD
Cyclophosphamide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000252	0.0163	CbGeAlD
Cyclophosphamide—CYP2C8—vagina—acquired immunodeficiency syndrome	0.00025	0.0162	CbGeAlD
Cyclophosphamide—CYP3A5—blood—acquired immunodeficiency syndrome	0.000244	0.0158	CbGeAlD
Cyclophosphamide—CYP2B6—blood—acquired immunodeficiency syndrome	0.000242	0.0157	CbGeAlD
Cyclophosphamide—CYP2C9—blood—acquired immunodeficiency syndrome	0.00024	0.0155	CbGeAlD
Cyclophosphamide—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000226	0.0146	CbGeAlD
Cyclophosphamide—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000225	0.0145	CbGeAlD
Cyclophosphamide—CYP3A5—lung—acquired immunodeficiency syndrome	0.000214	0.0138	CbGeAlD
Cyclophosphamide—CYP2B6—lung—acquired immunodeficiency syndrome	0.000212	0.0137	CbGeAlD
Cyclophosphamide—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000197	0.0127	CbGeAlD
Cyclophosphamide—ABCB1—retina—acquired immunodeficiency syndrome	0.000194	0.0125	CbGeAlD
Cyclophosphamide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000192	0.0124	CbGeAlD
Cyclophosphamide—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000189	0.0122	CbGeAlD
Cyclophosphamide—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000189	0.0122	CbGeAlD
Cyclophosphamide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000183	0.0118	CbGeAlD
Cyclophosphamide—CYP2D6—blood—acquired immunodeficiency syndrome	0.00018	0.0116	CbGeAlD
Cyclophosphamide—CYP2C8—brain—acquired immunodeficiency syndrome	0.000168	0.0108	CbGeAlD
Cyclophosphamide—CYP2B6—brain—acquired immunodeficiency syndrome	0.00015	0.00971	CbGeAlD
Cyclophosphamide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000149	0.0096	CbGeAlD
Cyclophosphamide—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000146	0.00944	CbGeAlD
Cyclophosphamide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000143	0.00924	CbGeAlD
Cyclophosphamide—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000141	0.00909	CbGeAlD
Cyclophosphamide—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000138	0.00889	CbGeAlD
Cyclophosphamide—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000136	0.00878	CbGeAlD
Cyclophosphamide—ABCB1—blood—acquired immunodeficiency syndrome	0.00013	0.00837	CbGeAlD
Cyclophosphamide—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000125	0.0081	CbGeAlD
Cyclophosphamide—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000125	0.00806	CbGeAlD
Cyclophosphamide—ABCB1—vagina—acquired immunodeficiency syndrome	0.00012	0.00776	CbGeAlD
Cyclophosphamide—ABCB1—lung—acquired immunodeficiency syndrome	0.000114	0.00733	CbGeAlD
Cyclophosphamide—CYP2D6—brain—acquired immunodeficiency syndrome	0.000112	0.00722	CbGeAlD
Cyclophosphamide—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000105	0.00679	CbGeAlD
Cyclophosphamide—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000529	CcSEcCtD
Cyclophosphamide—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000529	CcSEcCtD
Cyclophosphamide—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000528	CcSEcCtD
Cyclophosphamide—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000528	CcSEcCtD
Cyclophosphamide—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000527	CcSEcCtD
Cyclophosphamide—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000527	CcSEcCtD
Cyclophosphamide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000103	0.000527	CcSEcCtD
Cyclophosphamide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000525	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000524	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.000524	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000523	CcSEcCtD
Cyclophosphamide—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000522	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000102	0.000522	CcSEcCtD
Cyclophosphamide—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000522	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000522	CcSEcCtD
Cyclophosphamide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000102	0.000519	CcSEcCtD
Cyclophosphamide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000102	0.000519	CcSEcCtD
Cyclophosphamide—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000519	CcSEcCtD
Cyclophosphamide—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000519	CcSEcCtD
Cyclophosphamide—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000518	CcSEcCtD
Cyclophosphamide—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000518	CcSEcCtD
Cyclophosphamide—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000101	0.00654	CbGeAlD
Cyclophosphamide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000516	CcSEcCtD
Cyclophosphamide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000101	0.000515	CcSEcCtD
Cyclophosphamide—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000515	CcSEcCtD
Cyclophosphamide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000515	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000101	0.000515	CcSEcCtD
Cyclophosphamide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000101	0.000514	CcSEcCtD
Cyclophosphamide—Cough—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000512	CcSEcCtD
Cyclophosphamide—Headache—Didanosine—acquired immunodeficiency syndrome	0.0001	0.000512	CcSEcCtD
Cyclophosphamide—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.0001	0.000511	CcSEcCtD
Cyclophosphamide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.0001	0.00051	CcSEcCtD
Cyclophosphamide—Shock—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.00051	CcSEcCtD
Cyclophosphamide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000509	CcSEcCtD
Cyclophosphamide—Asthenia—Stavudine—acquired immunodeficiency syndrome	9.98e-05	0.000509	CcSEcCtD
Cyclophosphamide—Convulsion—Ritonavir—acquired immunodeficiency syndrome	9.98e-05	0.000509	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	9.96e-05	0.000508	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	9.95e-05	0.000507	CcSEcCtD
Cyclophosphamide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	9.94e-05	0.000507	CcSEcCtD
Cyclophosphamide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	9.92e-05	0.000506	CcSEcCtD
Cyclophosphamide—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	9.92e-05	0.000506	CcSEcCtD
Cyclophosphamide—Tremor—Lamivudine—acquired immunodeficiency syndrome	9.91e-05	0.000505	CcSEcCtD
Cyclophosphamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	9.87e-05	0.000503	CcSEcCtD
Cyclophosphamide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	9.86e-05	0.000502	CcSEcCtD
Cyclophosphamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	9.84e-05	0.000502	CcSEcCtD
Cyclophosphamide—Asthenia—Abacavir—acquired immunodeficiency syndrome	9.83e-05	0.000501	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	9.83e-05	0.000501	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	9.81e-05	0.0005	CcSEcCtD
Cyclophosphamide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	9.81e-05	0.0005	CcSEcCtD
Cyclophosphamide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	9.81e-05	0.0005	CcSEcCtD
Cyclophosphamide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	9.81e-05	0.0005	CcSEcCtD
Cyclophosphamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	9.77e-05	0.000498	CcSEcCtD
Cyclophosphamide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	9.77e-05	0.000498	CcSEcCtD
Cyclophosphamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.69e-05	0.000494	CcSEcCtD
Cyclophosphamide—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.69e-05	0.000494	CcSEcCtD
Cyclophosphamide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	9.69e-05	0.000494	CcSEcCtD
Cyclophosphamide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	9.69e-05	0.000494	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.68e-05	0.000493	CcSEcCtD
Cyclophosphamide—Cough—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.000493	CcSEcCtD
Cyclophosphamide—Constipation—Indinavir—acquired immunodeficiency syndrome	9.61e-05	0.00049	CcSEcCtD
Cyclophosphamide—Pain—Indinavir—acquired immunodeficiency syndrome	9.61e-05	0.00049	CcSEcCtD
Cyclophosphamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	9.6e-05	0.000489	CcSEcCtD
Cyclophosphamide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	9.6e-05	0.000489	CcSEcCtD
Cyclophosphamide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.57e-05	0.000488	CcSEcCtD
Cyclophosphamide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.56e-05	0.000487	CcSEcCtD
Cyclophosphamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.55e-05	0.000487	CcSEcCtD
Cyclophosphamide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	9.54e-05	0.000486	CcSEcCtD
Cyclophosphamide—Malaise—Lamivudine—acquired immunodeficiency syndrome	9.54e-05	0.000486	CcSEcCtD
Cyclophosphamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.52e-05	0.000485	CcSEcCtD
Cyclophosphamide—Nausea—Didanosine—acquired immunodeficiency syndrome	9.52e-05	0.000485	CcSEcCtD
Cyclophosphamide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	9.5e-05	0.000484	CcSEcCtD
Cyclophosphamide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	9.48e-05	0.000483	CcSEcCtD
Cyclophosphamide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	9.47e-05	0.000483	CcSEcCtD
Cyclophosphamide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	9.47e-05	0.000482	CcSEcCtD
Cyclophosphamide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	9.44e-05	0.000481	CcSEcCtD
Cyclophosphamide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.44e-05	0.000481	CcSEcCtD
Cyclophosphamide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	9.44e-05	0.000481	CcSEcCtD
Cyclophosphamide—Oedema—Ritonavir—acquired immunodeficiency syndrome	9.4e-05	0.000479	CcSEcCtD
Cyclophosphamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.38e-05	0.000478	CcSEcCtD
Cyclophosphamide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	9.32e-05	0.000475	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.27e-05	0.000472	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.26e-05	0.000472	CcSEcCtD
Cyclophosphamide—Shock—Ritonavir—acquired immunodeficiency syndrome	9.25e-05	0.000471	CcSEcCtD
Cyclophosphamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	9.23e-05	0.000471	CcSEcCtD
Cyclophosphamide—Cough—Lamivudine—acquired immunodeficiency syndrome	9.23e-05	0.00047	CcSEcCtD
Cyclophosphamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.23e-05	0.00047	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.2e-05	0.000469	CcSEcCtD
Cyclophosphamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.2e-05	0.000469	CcSEcCtD
Cyclophosphamide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	9.17e-05	0.000468	CcSEcCtD
Cyclophosphamide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	9.16e-05	0.000467	CcSEcCtD
Cyclophosphamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.16e-05	0.000467	CcSEcCtD
Cyclophosphamide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.16e-05	0.000467	CcSEcCtD
Cyclophosphamide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	9.13e-05	0.000465	CcSEcCtD
Cyclophosphamide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	9.12e-05	0.000465	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	9.09e-05	0.000463	CcSEcCtD
Cyclophosphamide—Pain—Efavirenz—acquired immunodeficiency syndrome	9.08e-05	0.000463	CcSEcCtD
Cyclophosphamide—Constipation—Efavirenz—acquired immunodeficiency syndrome	9.08e-05	0.000463	CcSEcCtD
Cyclophosphamide—Rash—Nevirapine—acquired immunodeficiency syndrome	9.08e-05	0.000463	CcSEcCtD
Cyclophosphamide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.08e-05	0.000463	CcSEcCtD
Cyclophosphamide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	9.06e-05	0.000462	CcSEcCtD
Cyclophosphamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.06e-05	0.000462	CcSEcCtD
Cyclophosphamide—Oedema—Saquinavir—acquired immunodeficiency syndrome	9.05e-05	0.000461	CcSEcCtD
Cyclophosphamide—Headache—Nevirapine—acquired immunodeficiency syndrome	9.03e-05	0.00046	CcSEcCtD
Cyclophosphamide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	9e-05	0.000459	CcSEcCtD
Cyclophosphamide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9e-05	0.000459	CcSEcCtD
Cyclophosphamide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	9e-05	0.000459	CcSEcCtD
Cyclophosphamide—Infection—Saquinavir—acquired immunodeficiency syndrome	8.99e-05	0.000458	CcSEcCtD
Cyclophosphamide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	8.96e-05	0.000457	CcSEcCtD
Cyclophosphamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	8.93e-05	0.000455	CcSEcCtD
Cyclophosphamide—Shock—Saquinavir—acquired immunodeficiency syndrome	8.9e-05	0.000454	CcSEcCtD
Cyclophosphamide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	8.9e-05	0.000453	CcSEcCtD
Cyclophosphamide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	8.89e-05	0.000453	CcSEcCtD
Cyclophosphamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	8.87e-05	0.000452	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	8.86e-05	0.000451	CcSEcCtD
Cyclophosphamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	8.84e-05	0.000451	CcSEcCtD
Cyclophosphamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	8.84e-05	0.00045	CcSEcCtD
Cyclophosphamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	8.8e-05	0.000448	CcSEcCtD
Cyclophosphamide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	8.79e-05	0.000448	CcSEcCtD
Cyclophosphamide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	8.78e-05	0.000448	CcSEcCtD
Cyclophosphamide—Rash—Stavudine—acquired immunodeficiency syndrome	8.77e-05	0.000447	CcSEcCtD
Cyclophosphamide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	8.76e-05	0.000447	CcSEcCtD
Cyclophosphamide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	8.76e-05	0.000447	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	8.75e-05	0.000446	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	8.75e-05	0.000446	CcSEcCtD
Cyclophosphamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	8.74e-05	0.000445	CcSEcCtD
Cyclophosphamide—Headache—Stavudine—acquired immunodeficiency syndrome	8.71e-05	0.000444	CcSEcCtD
Cyclophosphamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	8.71e-05	0.000444	CcSEcCtD
Cyclophosphamide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	8.7e-05	0.000444	CcSEcCtD
Cyclophosphamide—Pain—Delavirdine—acquired immunodeficiency syndrome	8.69e-05	0.000443	CcSEcCtD
Cyclophosphamide—Constipation—Delavirdine—acquired immunodeficiency syndrome	8.69e-05	0.000443	CcSEcCtD
Cyclophosphamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.67e-05	0.000442	CcSEcCtD
Cyclophosphamide—Rash—Abacavir—acquired immunodeficiency syndrome	8.64e-05	0.00044	CcSEcCtD
Cyclophosphamide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.63e-05	0.00044	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	8.63e-05	0.00044	CcSEcCtD
Cyclophosphamide—Oedema—Lamivudine—acquired immunodeficiency syndrome	8.63e-05	0.00044	CcSEcCtD
Cyclophosphamide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	8.62e-05	0.000439	CcSEcCtD
Cyclophosphamide—Headache—Abacavir—acquired immunodeficiency syndrome	8.58e-05	0.000437	CcSEcCtD
Cyclophosphamide—Infection—Lamivudine—acquired immunodeficiency syndrome	8.57e-05	0.000437	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.56e-05	0.000436	CcSEcCtD
Cyclophosphamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.56e-05	0.000436	CcSEcCtD
Cyclophosphamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.55e-05	0.000436	CcSEcCtD
Cyclophosphamide—Shock—Lamivudine—acquired immunodeficiency syndrome	8.49e-05	0.000433	CcSEcCtD
Cyclophosphamide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	8.45e-05	0.000431	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.45e-05	0.000431	CcSEcCtD
Cyclophosphamide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8.44e-05	0.00043	CcSEcCtD
Cyclophosphamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	8.44e-05	0.00043	CcSEcCtD
Cyclophosphamide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.4e-05	0.000428	CcSEcCtD
Cyclophosphamide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.38e-05	0.000427	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.38e-05	0.000427	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	8.34e-05	0.000425	CcSEcCtD
Cyclophosphamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.29e-05	0.000422	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.28e-05	0.000422	CcSEcCtD
Cyclophosphamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.27e-05	0.000422	CcSEcCtD
Cyclophosphamide—Nausea—Stavudine—acquired immunodeficiency syndrome	8.26e-05	0.000421	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.24e-05	0.00042	CcSEcCtD
Cyclophosphamide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	8.23e-05	0.000419	CcSEcCtD
Cyclophosphamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	8.17e-05	0.000416	CcSEcCtD
Cyclophosphamide—Nausea—Abacavir—acquired immunodeficiency syndrome	8.14e-05	0.000415	CcSEcCtD
Cyclophosphamide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.12e-05	0.000414	CcSEcCtD
Cyclophosphamide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.1e-05	0.000413	CcSEcCtD
Cyclophosphamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.07e-05	0.000412	CcSEcCtD
Cyclophosphamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.07e-05	0.000411	CcSEcCtD
Cyclophosphamide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.07e-05	0.000411	CcSEcCtD
Cyclophosphamide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	8.06e-05	0.000411	CcSEcCtD
Cyclophosphamide—ABCB1—brain—acquired immunodeficiency syndrome	8.04e-05	0.00519	CbGeAlD
Cyclophosphamide—Pain—Ritonavir—acquired immunodeficiency syndrome	8.04e-05	0.00041	CcSEcCtD
Cyclophosphamide—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.04e-05	0.00041	CcSEcCtD
Cyclophosphamide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.04e-05	0.00041	CcSEcCtD
Cyclophosphamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	7.99e-05	0.000407	CcSEcCtD
Cyclophosphamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	7.95e-05	0.000405	CcSEcCtD
Cyclophosphamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	7.86e-05	0.000401	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	7.86e-05	0.000401	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	7.83e-05	0.000399	CcSEcCtD
Cyclophosphamide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	7.8e-05	0.000398	CcSEcCtD
Cyclophosphamide—ABCB1—lymph node—acquired immunodeficiency syndrome	7.77e-05	0.00502	CbGeAlD
Cyclophosphamide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	7.75e-05	0.000395	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	7.75e-05	0.000395	CcSEcCtD
Cyclophosphamide—Pain—Saquinavir—acquired immunodeficiency syndrome	7.74e-05	0.000394	CcSEcCtD
Cyclophosphamide—Constipation—Saquinavir—acquired immunodeficiency syndrome	7.74e-05	0.000394	CcSEcCtD
Cyclophosphamide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	7.69e-05	0.000392	CcSEcCtD
Cyclophosphamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.69e-05	0.000392	CcSEcCtD
Cyclophosphamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.69e-05	0.000392	CcSEcCtD
Cyclophosphamide—Rash—Zidovudine—acquired immunodeficiency syndrome	7.62e-05	0.000388	CcSEcCtD
Cyclophosphamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.62e-05	0.000388	CcSEcCtD
Cyclophosphamide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.62e-05	0.000388	CcSEcCtD
Cyclophosphamide—Headache—Zidovudine—acquired immunodeficiency syndrome	7.57e-05	0.000386	CcSEcCtD
Cyclophosphamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.52e-05	0.000383	CcSEcCtD
Cyclophosphamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.5e-05	0.000382	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.49e-05	0.000382	CcSEcCtD
Cyclophosphamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.47e-05	0.000381	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.46e-05	0.00038	CcSEcCtD
Cyclophosphamide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.44e-05	0.000379	CcSEcCtD
Cyclophosphamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.44e-05	0.000379	CcSEcCtD
Cyclophosphamide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.43e-05	0.000379	CcSEcCtD
Cyclophosphamide—Pain—Lamivudine—acquired immunodeficiency syndrome	7.38e-05	0.000376	CcSEcCtD
Cyclophosphamide—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.38e-05	0.000376	CcSEcCtD
Cyclophosphamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.29e-05	0.000372	CcSEcCtD
Cyclophosphamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.27e-05	0.00037	CcSEcCtD
Cyclophosphamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.19e-05	0.000366	CcSEcCtD
Cyclophosphamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.19e-05	0.000366	CcSEcCtD
Cyclophosphamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.18e-05	0.000366	CcSEcCtD
Cyclophosphamide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.15e-05	0.000364	CcSEcCtD
Cyclophosphamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.15e-05	0.000364	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.000362	CcSEcCtD
Cyclophosphamide—Rash—Indinavir—acquired immunodeficiency syndrome	7.09e-05	0.000361	CcSEcCtD
Cyclophosphamide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.08e-05	0.000361	CcSEcCtD
Cyclophosphamide—Headache—Indinavir—acquired immunodeficiency syndrome	7.04e-05	0.000359	CcSEcCtD
Cyclophosphamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.02e-05	0.000358	CcSEcCtD
Cyclophosphamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	6.95e-05	0.000354	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	6.93e-05	0.000353	CcSEcCtD
Cyclophosphamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	6.86e-05	0.000349	CcSEcCtD
Cyclophosphamide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	6.82e-05	0.000348	CcSEcCtD
Cyclophosphamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.75e-05	0.000344	CcSEcCtD
Cyclophosphamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.74e-05	0.000344	CcSEcCtD
Cyclophosphamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.72e-05	0.000343	CcSEcCtD
Cyclophosphamide—Rash—Efavirenz—acquired immunodeficiency syndrome	6.7e-05	0.000341	CcSEcCtD
Cyclophosphamide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.69e-05	0.000341	CcSEcCtD
Cyclophosphamide—Nausea—Indinavir—acquired immunodeficiency syndrome	6.68e-05	0.00034	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	6.67e-05	0.00034	CcSEcCtD
Cyclophosphamide—Headache—Efavirenz—acquired immunodeficiency syndrome	6.66e-05	0.000339	CcSEcCtD
Cyclophosphamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.65e-05	0.000339	CcSEcCtD
Cyclophosphamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.49e-05	0.000331	CcSEcCtD
Cyclophosphamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.46e-05	0.000329	CcSEcCtD
Cyclophosphamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.43e-05	0.000328	CcSEcCtD
Cyclophosphamide—Rash—Delavirdine—acquired immunodeficiency syndrome	6.41e-05	0.000327	CcSEcCtD
Cyclophosphamide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.4e-05	0.000326	CcSEcCtD
Cyclophosphamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.4e-05	0.000326	CcSEcCtD
Cyclophosphamide—Headache—Delavirdine—acquired immunodeficiency syndrome	6.37e-05	0.000325	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.36e-05	0.000324	CcSEcCtD
Cyclophosphamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.31e-05	0.000322	CcSEcCtD
Cyclophosphamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.22e-05	0.000317	CcSEcCtD
Cyclophosphamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.19e-05	0.000316	CcSEcCtD
Cyclophosphamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.19e-05	0.000315	CcSEcCtD
Cyclophosphamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.11e-05	0.000311	CcSEcCtD
Cyclophosphamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.04e-05	0.000308	CcSEcCtD
Cyclophosphamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	5.98e-05	0.000305	CcSEcCtD
Cyclophosphamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.98e-05	0.000305	CcSEcCtD
Cyclophosphamide—Rash—Ritonavir—acquired immunodeficiency syndrome	5.93e-05	0.000302	CcSEcCtD
Cyclophosphamide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	5.92e-05	0.000302	CcSEcCtD
Cyclophosphamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	5.91e-05	0.000301	CcSEcCtD
Cyclophosphamide—Headache—Ritonavir—acquired immunodeficiency syndrome	5.89e-05	0.0003	CcSEcCtD
Cyclophosphamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.75e-05	0.000293	CcSEcCtD
Cyclophosphamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.71e-05	0.000291	CcSEcCtD
Cyclophosphamide—Rash—Saquinavir—acquired immunodeficiency syndrome	5.7e-05	0.000291	CcSEcCtD
Cyclophosphamide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.7e-05	0.00029	CcSEcCtD
Cyclophosphamide—Headache—Saquinavir—acquired immunodeficiency syndrome	5.67e-05	0.000289	CcSEcCtD
Cyclophosphamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.58e-05	0.000285	CcSEcCtD
Cyclophosphamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.49e-05	0.00028	CcSEcCtD
Cyclophosphamide—Rash—Lamivudine—acquired immunodeficiency syndrome	5.44e-05	0.000277	CcSEcCtD
Cyclophosphamide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.44e-05	0.000277	CcSEcCtD
Cyclophosphamide—Headache—Lamivudine—acquired immunodeficiency syndrome	5.41e-05	0.000276	CcSEcCtD
Cyclophosphamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.37e-05	0.000274	CcSEcCtD
Cyclophosphamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.13e-05	0.000261	CcSEcCtD
